Artículo especial
Grado de innovación de los nuevos medicamentos: propuesta de criterios que deben tenerse en cuenta para su valoración
Innovation degree of new drugs: Proposal of criteria to be considered for their assessment
Javier Soto Álvarez
Departamento de Investigación de Resultados en Salud y Farmacoeconomía, Unidad Médica de Pfizer S. A., Madrid, España
Leído
2221
Vecesse ha leído el artículo
218
Total PDF
2003
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2023 3 | 2 | 2 | 4 |
| 2021 11 | 0 | 2 | 2 |
| 2017 10 | 8 | 0 | 8 |
| 2017 9 | 11 | 9 | 20 |
| 2017 8 | 12 | 1 | 13 |
| 2017 7 | 11 | 1 | 12 |
| 2017 6 | 34 | 0 | 34 |
| 2017 5 | 22 | 3 | 25 |
| 2017 4 | 22 | 3 | 25 |
| 2017 3 | 24 | 19 | 43 |
| 2017 2 | 25 | 0 | 25 |
| 2016 1 | 17 | 2 | 19 |
| 2016 12 | 30 | 3 | 33 |
| 2016 11 | 50 | 2 | 52 |
| 2016 10 | 36 | 3 | 39 |
| 2016 9 | 44 | 3 | 47 |
| 2016 8 | 38 | 2 | 40 |
| 2016 7 | 23 | 1 | 24 |
| 2016 6 | 29 | 12 | 41 |
| 2016 5 | 32 | 4 | 36 |
| 2016 4 | 26 | 8 | 34 |
| 2016 3 | 34 | 5 | 39 |
| 2016 2 | 25 | 5 | 30 |
| 2015 1 | 38 | 6 | 44 |
| 2015 12 | 24 | 9 | 33 |
| 2015 11 | 31 | 3 | 34 |
| 2015 10 | 47 | 4 | 51 |
| 2015 9 | 48 | 8 | 56 |
| 2015 8 | 22 | 4 | 26 |
| 2015 7 | 15 | 4 | 19 |
| 2015 6 | 15 | 3 | 18 |
| 2015 5 | 23 | 1 | 24 |
| 2015 4 | 21 | 9 | 30 |
| 2015 3 | 19 | 4 | 23 |
| 2015 2 | 17 | 5 | 22 |
| 2015 1 | 28 | 3 | 31 |
| 2014 12 | 35 | 5 | 40 |
| 2014 11 | 26 | 3 | 29 |
| 2014 10 | 32 | 2 | 34 |
| 2014 9 | 28 | 3 | 31 |
| 2014 8 | 24 | 2 | 26 |
| 2014 7 | 47 | 4 | 51 |
| 2014 6 | 33 | 4 | 37 |
| 2014 5 | 35 | 2 | 37 |
| 2014 4 | 13 | 3 | 16 |
| 2014 3 | 21 | 4 | 25 |
| 2014 2 | 22 | 2 | 24 |
| 2014 1 | 20 | 3 | 23 |
| 2013 12 | 29 | 4 | 33 |
| 2013 11 | 37 | 15 | 52 |
| 2013 10 | 37 | 1 | 38 |
| 2013 9 | 14 | 5 | 19 |
| 2013 8 | 17 | 3 | 20 |
| 2013 7 | 19 | 0 | 19 |
| 2013 5 | 1 | 0 | 1 |
| 2009 4 | 610 | 0 | 610 |
Mostrar todo
